OE19
Strain Information
表現型データ
I. Characterization of in vivo growth kinetics
The OE19 cells were subcutaneously inoculated into the M-NSG mice (NM-NSG-001) and huPBMC-(M-NSG) mice (NM-NSG-015).
Figure 1. Tumor growth curve of OE19 xenograft model (n=6)
Figure 2. Body weight change of OE19 xenograft model (n=6)
*Wild-type cell lines are not for sale, and only applied to construction of tumor bearing mice and in-vivo efficacy studies.
関連の系統
あなたも好きかも
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
詳細Our vision is to provide researchers all over the world with comprehensive, convenient and professional animal model services to facilitate a simplified and highly-efficient approach towards uncovering the mysteries of life.
詳細